Drug Profile
SC 57461
Alternative Names: SC 57461ALatest Information Update: 12 Sep 2006
Price :
$50
*
At a glance
- Originator Pfizer
- Class Anti-inflammatories; Antipsoriatics
- Mechanism of Action Leukotriene A4 hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammatory bowel diseases